ArticleJournal of oral biology and craniofacial research
Development and validation of an AI-based application for early detection and risk stratification of oral potentially malignant disorders.
Article in Journal of oral biology and craniofacial research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mobile AI-Assisted Oral Lesion Triage for Community Oral Cancer Screening: Prospective Field Evaluation Study.JMIR mHealth and uHealth · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oral Potentially Malignant Disorders (OPMDs) are early indicators of oral cancer, and timely detection is essential for improving patient outcomes. However, diagnosis often relies on expert clinical evaluation, which may not be available in low-resource settings. Objective: This study presents the development and validation of PRAYAAS, an AI-based mobile application for early detection and risk stratification of OPMDs using intraoral images. Methods: A total of 794 intraoral images were classified into three categories: (1) Normal mucosa/inflammatory conditions, (2) Premalignant conditions, and (3) Oral carcinoma. Images were split into training (70 %), validation (18 %), and test (12 %) datasets while maintaining class balance. Preprocessing involved resizing to 224 × 224 pixels, contrast enhancement, and normalization. A U-Net-based model segmented lesion regions, followed by classification using a fine-tuned DenseNet201 model. Model performance was evaluated using accuracy, precision, recall, F1-score, and confusion matrices. Results: The DenseNet201 classifier achieved 94 % accuracy on the test set. For normal/inflammatory lesions, precision and recall were 1.00. For premalignant lesions, precision was 0.87 and recall was 1.00. For carcinoma, precision was 1.00 and recall was 0.80. The integrated segmentation module improved lesion focus and reduced background noise. The app provides class-wise risk scores and a user-friendly interface for clinical support. Conclusion: PRAYAAS offers a robust, mobile-enabled solution for early OPMD screening. By integrating segmentation and classification into a single platform, the tool holds promise for enhancing community-based oral cancer detection and referral.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.